Goldman M B, French D L, Goldman J N
J Immunol. 1979 Jan;122(1):246-52.
Suppression of levels of circulating C5 in (C5- C5+)F1 hybrids by administration of (C5- C5-) parental lymphoid cells in the neonatal period has been accomplished with the three strain combinations tested ((SWR X RIII)F1, (A/He x RIII)F1, and (SWR X DBA/1)F1). Suppression was shown to be specific for C5 and not accompanied by reductions of C1, C2, C6, or other major groups of blood proteins. This demonstrated that the C5 reduction was not due to activation of complement (C) with resultant hypercatabolism of C components. When there was a concurrent chronic GVH reaction induced by lymphoid cells administered to offspring of H-2 incompatible parents, there was usually a resultant hypergammaglobulinemia that was also unrelated to the presence or absence of C5 suppression. Effective suppression required preimmunization of either the cell donor, the mother of the F1 hybrids, or both. This suggests that either two cell types or a single cell plus a humoral factor are required for suppression in this system.
在新生期给(C5 - C5 +)F1杂种小鼠注射(C5 - C5 -)亲本淋巴细胞,已成功在三种测试的品系组合((SWR×RIII)F1、(A/He×RIII)F1和(SWR×DBA/1)F1)中抑制了循环C5水平。抑制作用显示对C5具有特异性,且未伴有C1、C2、C6或其他主要血液蛋白组的减少。这表明C5的降低并非由于补体(C)的激活以及随之而来的C成分的高分解代谢。当给H - 2不相容亲本的后代注射淋巴细胞诱导同时发生慢性移植物抗宿主反应时,通常会导致高丙种球蛋白血症,这也与C5抑制的存在与否无关。有效的抑制需要对细胞供体、F1杂种小鼠的母亲或两者进行预先免疫。这表明在该系统中抑制作用需要两种细胞类型或一种细胞加一种体液因子。